Trial · NCT00716144
Results by group168
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 168
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Psoriasis Area Severity Index (PASI)75 Success at Visit 6 | Placebo | 4 | Participants | ||
| Psoriasis Area Severity Index (PASI)75 Success at Visit 6 | R115866 0.5 mg | 7 | Participants | ||
| Psoriasis Area Severity Index (PASI)75 Success at Visit 6 | R115866 1.0 mg | 4 | Participants | ||
| Psoriasis Area Severity Index (PASI)75 Success at Visit 6 | R115866 2.0 mg | 5 | Participants | ||
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | Placebo | Visit 3 | 0 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 0.5 mg | Visit 3 | 0 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 1.0 mg | Visit 3 | 0 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 2.0 mg | Visit 3 | 0 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | Placebo | Visit 4 | 2 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 0.5 mg | Visit 4 | 0 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 1.0 mg | Visit 4 | 1 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 2.0 mg | Visit 4 | 1 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | Placebo | Visit 5 | 7 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 0.5 mg | Visit 5 | 9 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 1.0 mg | Visit 5 | 8 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 2.0 mg | Visit 5 | 11 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | Placebo | Visit 6 | 8 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 0.5 mg | Visit 6 | 18 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 1.0 mg | Visit 6 | 18 | Participants | |
| PASI50 Success (the Reduction in PASI Score at Each Visit of at Least 50 Percent Relative to Visit 2) at Each Post Baseline Visit | R115866 2.0 mg | Visit 6 | 19 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT00716144/results